Xxentria Technology Materials Co., Ltd. (TPEX:8942)

Elevation Oncology Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 12, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	8,630	10,220	13,171	9,801	11,294	9,934
Market Cap Growth	-14.43%	-22.40%	34.38%	-13.22%	13.69%	-7.90%
Enterprise Value	10,640	11,933	17,100	14,210	13,900	9,989
Last Close Price	43.40	49.72	60.10	42.65	45.82	38.23
PE Ratio	9.25	9.54	8.23	7.49	8.78	10.50
Forward PE	-	11.30	11.30	11.30	11.30	11.30
PS Ratio	1.87	2.37	2.37	1.72	2.09	3.23
PB Ratio	0.82	0.96	1.30	1.09	1.37	1.28
P/TBV Ratio	0.93	1.10	1.44	1.23	1.48	1.42
P/FCF Ratio	12.55	10.64	-	4.39	-	58.29
P/OCF Ratio	8.81	7.53	15.02	3.29	93.95	17.50
EV/Sales Ratio	2.30	2.77	3.08	2.50	2.58	3.25
EV/EBITDA Ratio	10.28	13.70	9.76	10.27	13.40	13.98
EV/EBIT Ratio	13.50	18.40	11.01	12.08	16.64	20.02
EV/FCF Ratio	15.48	12.42	-	6.36	-	58.62
Debt / Equity Ratio	0.29	0.25	0.42	0.73	0.79	0.35
Debt / EBITDA Ratio	3.39	2.96	2.42	4.73	6.27	3.75
Debt / FCF Ratio	4.46	2.73	-	2.93	-	15.77
Asset Turnover	0.30	0.28	0.34	0.35	0.40	0.29
Inventory Turnover	2.28	1.88	2.23	2.51	3.22	2.05
Quick Ratio	1.04	1.06	0.76	0.60	0.61	1.56
Current Ratio	1.59	1.72	1.45	1.38	1.26	1.91
Return on Equity (ROE)	7.88%	9.56%	16.39%	13.72%	16.13%	12.55%
Return on Assets (ROA)	2.68%	2.66%	5.96%	4.52%	3.86%	2.92%
Return on Capital (ROIC)	2.97%	2.93%	6.48%	4.85%	4.15%	3.16%
Return on Capital Employed (ROCE)	5.50%	5.40%	13.30%	11.10%	9.60%	6.00%
Earnings Yield	10.81%	10.49%	12.15%	13.35%	11.39%	9.53%
FCF Yield	7.97%	9.40%	-1.18%	22.79%	-1.56%	1.71%
Dividend Yield	8.01%	7.04%	6.26%	6.84%	7.28%	6.54%
Payout Ratio	83.72%	69.78%	15.55%	57.04%	57.59%	69.28%
Buyback Yield / Dilution	0.01%	0.01%	0.00%	-0.75%	-0.44%	0.01%
Total Shareholder Return	8.02%	7.05%	6.26%	6.10%	6.84%	6.55%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.